Skip to content

Opening book details…

About this Medicine article

Recombinant IL-2 Shows Benefit in Younger AML Patients by Fuerst, Mark is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fuerst, Mark
Publisher
Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Ovid Technologies (Wolters Kluwer Health) (ISSN 0276-2234)
Published
2008
Field
Medicine (Health Sciences)

More by Fuerst, Mark

Browse all works by Fuerst, Mark